osaühing TBD Pharmatech
Active Registry code 11204964
OÜ Tartu linn Registered 10 Feb 2006
osaühing TBD Pharmatech is a OÜ based in Tartu linn, registry code 11204964, status: active. Main activity: Manufacture of basic pharmaceutical products. According to EMTA, turnover for Q3 2026 was €1 059 853 with 68 employees.
Turnover
1 059 853 €
↓ 36.5% vs Q2 2026
State taxes
271 790 €
↑ 6.3% vs Q2 2026
Labour taxes
294 698 €
↑ 6.0% vs Q2 2026
Employees
68
+5 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.1 mn €above 63% of companiesindustry median 234 187 € · companies in the industry: 12
- Labour taxes per employee 4 334 €above 45% of companiesindustry median 4 573 € · companies in the industry: 12
- Revenue · 2025 5.1 mn €above 85% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 9.8 %above 50% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 059 853 | 271 790 | 294 698 | 68 |
| Q2 2026 | 1 670 268 | 255 753 | 277 947 | 63 |
| Q1 2026 | 806 286 | 264 048 | 266 694 | 65 |
| Q4 2025 | 920 165 | 313 615 | 335 152 | 64 |
| Q3 2025 | 2 096 033 | 268 821 | 301 460 | 67 |
| Q2 2025 | 861 235 | 242 558 | 260 572 | 67 |
| Q1 2025 | 1 926 458 | 269 060 | 289 193 | 59 |
| Q4 2024 | 1 172 092 | — | 225 063 | 59 |
| Q3 2024 | 1 789 465 | 68 806 | 228 729 | 58 |
| Q2 2024 | 1 517 829 | 224 216 | 240 261 | 58 |
| Q1 2024 | 1 685 144 | 225 221 | 236 777 | 63 |
| Q4 2023 | 971 857 | 201 863 | 213 991 | 59 |
| Q3 2023 | 699 169 | 227 222 | 239 670 | 62 |
| Q2 2023 | 1 614 406 | 186 006 | 199 986 | 61 |
| Q1 2023 | 1 166 585 | 202 565 | 216 919 | 63 |
| Q4 2022 | 1 622 487 | 174 587 | 187 465 | 68 |
| Q3 2022 | 1 572 999 | 180 643 | 194 185 | 64 |
| Q2 2022 | 803 527 | 160 191 | 171 976 | 60 |
| Q1 2022 | 1 696 526 | 160 988 | 172 622 | 56 |
Labour taxes per employee per month
1 445 €
Turnover per employee in the quarter
15 586 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 5 116 467 | 499 563 | 2 699 686 | 11 379 553 | 6 829 858 | 62 |
| 2024 | 6 286 179 | 1 450 675 | 2 400 332 | 11 731 557 | 6 330 295 | 58 |
| 2023 | 4 115 740 | -179 441 | 2 159 112 | 5 527 121 | 4 879 620 | 58 |
| 2022 | 5 168 441 | 234 758 | 1 825 321 | 5 965 767 | 5 058 497 | 60 |
| 2021 | 4 841 495 | 1 292 402 | 1 492 396 | 5 351 538 | 4 823 739 | 48 |
| 2020 | 4 568 917 | 1 469 997 | 1 258 223 | 3 895 176 | 3 531 337 | 44 |
| 2019 | 3 255 697 | 946 069 | 922 355 | 2 437 126 | 2 061 340 | 35 |
| 2018 | — | — | — | — | — | 22 |
| 2017 | — | — | — | — | — | 21 |
| 2016 | — | — | — | — | — | 18 |
| 2015 | — | — | — | — | — | 18 |
| 2014 | — | — | — | — | — | 18 |
| 2013 | — | — | — | — | — | 12 |
| 2012 | — | — | — | — | — | 16 |
| 2011 | — | — | — | — | — | 17 |
| 2010 | — | — | — | — | — | 13 |
| 2009 | — | — | — | — | — | 9 |
| 2008 | — | — | — | — | — | 8 |
| 2007 | — | — | — | — | — | 3 |
| 2006 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
9.8 %
Net profit / revenue
Return on equity (ROE)
7.3 %
Net profit / equity
Return on assets (ROA)
4.4 %
Net profit / assets
Equity ratio
60.0 %
Equity / assets
Debt ratio
40.0 %
Liabilities / assets
Current ratio
3.80
Current assets / current liabilities
Revenue per employee
82 524 €
Revenue / average full-time employees
Labour cost per employee per month
3 629 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 29 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 17 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 25 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 27 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 24 May 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 24 May 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 20 May 2020 | Company’s own · audited | e-Äriregister |
Board
- Andrus TasaBoard member · since 18 Apr 2017
- Tõnis TasaBoard member · since 13 Jun 2024
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- KEMINVENT OÜLegal person · 12771636 · 4 995 €
- SEAL Investments B.V.Legal person · 2 141 €
Beneficial owners
- Andrus TasaIndirect ownership · since 11 Sep 2018
Founders and other persons
- Ago RinkenFounder · 12 000 € · 1 Feb 2006
- Allan NurkFounder · 12 000 € · 1 Feb 2006
- Margus PoogaFounder · 4 000 € · 1 Feb 2006
- Uno MäeorgFounder · 12 000 € · 1 Feb 2006
- Ursel SoometsFounder · 4 000 € · 1 Feb 2006
- aktsiaselts Tartu Biotehnoloogia ParkFounder · 24 000 € · 1 Feb 2006
Related companies
Activities (EMTAK)
- 21101Manufacture of basic pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20034659 / 23 13 Jun 2024 |
Amendment entry | In force 13 Jun 2024 |
||
| Ä 20034659 / 22 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 20034659 / 21 12 Jun 2023 |
Amendment entry | In force 12 Jun 2023 |
||
| Ä 20034659 / 20 13 Jan 2023 |
Amendment entry | In force 13 Jan 2023 |
||
| Ä 20034659 / M7 9 Jan 2023 |
Ruling to eliminate deficiencies | 24 Jan 2023 | Deficiencies eliminated 13 Jan 2023 |
|
| Ä 20034659 / 19 24 Apr 2019 |
Amendment entry | In force 24 Apr 2019 |
||
| Ä 20034659 / 18 17 Dec 2018 |
Amendment entry | In force 17 Dec 2018 |
||
| Ä 20034659 / 17 14 May 2018 |
Amendment entry | In force 14 May 2018 |
||
| Ä 20034659 / 16 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 20034659 / 15 22 Dec 2017 |
Amendment entry | In force 22 Dec 2017 |
||
| Ä 20034659 / 14 4 Dec 2017 |
Amendment entry | In force 4 Dec 2017 |
||
| Ä 20034659 / 13 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 20034659 / 12 22 May 2017 |
Amendment entry | In force 22 May 2017 |
||
| Ä 20034659 / M6 12 May 2017 |
Ruling to eliminate deficiencies | 26 May 2017 | Deficiencies eliminated 22 May 2017 |
|
| Ä 20034659 / 11 18 Apr 2017 |
Amendment entry | In force 18 Apr 2017 |
||
| Ä 20034659 / M5 6 Jul 2016 |
Refund of the state fee | In force 6 Jul 2016 |
||
| Ä 20034659 / 10 7 Oct 2015 |
Amendment entry | In force 7 Oct 2015 |
||
| Ä 20034659 / M4 24 Sep 2015 |
Ruling to eliminate deficiencies | 24 Oct 2015 | Deficiencies eliminated 6 Oct 2015 |
|
| Ä 20034659 / 9 16 Jul 2015 |
Amendment entry | In force 16 Jul 2015 |
||
| Ä 20034659 / 8 30 Jan 2015 |
Amendment entry | In force 30 Jan 2015 |
||
| Ä 20034659 / 7 18 Nov 2014 |
Amendment entry | In force 18 Nov 2014 |
||
| Ä 20034659 / M3 3 Apr 2013 |
Ruling to correct data outside an entry | 3 May 2013 | Deficiencies eliminated 8 Apr 2013 |
|
| Ä 20034659 / 6 9 Jan 2012 |
Amendment entry | In force 9 Jan 2012 |
||
| Ä 20034659 / M2 4 Jan 2012 |
Ruling to eliminate deficiencies | 4 Feb 2012 | In force 4 Jan 2012 |
|
| Ä 34659 / 5 21 May 2009 |
Amendment entry | In force 22 May 2009 |
||
| Ä 34659 / M1 15 May 2009 |
Ruling to eliminate deficiencies | In force 15 May 2009 |
||
| Ä 34659 / 4 12 Jan 2009 |
Amendment entry | In force 12 Jan 2009 |
||
| Ä 34659 / 3 3 Dec 2008 |
Deletion of activities from the registry card | In force 22 Dec 2008 |
||
| Ä 34659 / 2 25 Jan 2007 |
Amendment entry | In force 26 Jan 2007 |
||
| Ä 34659 8 Feb 2006 |
First entry | In force 10 Feb 2006 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data